The latest lymphoma news
New drugs are improving survival times for patients with aggressive type of blood cancer
Survival times for a highly aggressive type of blood cancer have nearly doubled over the…
The latest lymphoma news
Survival times for a highly aggressive type of blood cancer have nearly doubled over the…
Treatment changes including the advent of targeted and immune therapies have dramatically improved survival for…
Austrian researchers have discovered that a small number of patients taking targeted drugs known as…
The majority of patients with diffuse large B cell lymphoma (DLBCL) can be treated effectively.…
Survivors of adolescent and young adult cancer often have stronger social networks than their non-cancer…
Patients with a history of breast cancer or lymphoma were more than three times as…
A team of scientists at the Keck School of Medicine of USC is looking to…
People who inherit genetic changes which alter the function of their immune system are at…
A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many…
Scientists from The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates…